Repligen Corp (NASDAQ: RGEN) reported Q4 EPS of $0.10, $0.04 worse than the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE